First Time Loading...

Burning Rock Biotech Ltd

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
Price: 0.97 USD +4.3% Market Closed
Updated: Oct 1, 2023

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Sep 30, 2023.

Estimated DCF Value of one BNR stock is -0.88 USD. Compared to the current market price of 0.97 USD, the stock is Overvalued by 100%.

Base Case
-0.88 USD
Overvaluation 100%
DCF Value
Worst Case
Base Case
Best Case
DCF Value
Worst Case
Base Case
Best Case
DCF Value: -0.88 USD
Burning Rock Biotech Ltd Competitors:
DCF Valuation
HLB Therapeutics Co Ltd
argenx SE
Dyadic International Inc
Frontier Biotechnologies Inc
Zenotech Laboratories Ltd
Curis Inc
Legend Biotech Corp
PharmaResearch Co Ltd

Present Value Calculation

The first step in the DCF calculation process is to estimate the company's future free cash flow. Once free cash flow is forecasted, it is discounted at a risk-appropriate discount rate. The resulting value is the present value of the company's free cash flow. You can change any model inputs below.

Available Valuation Models
1 valuation model available
Alpha Spread
Updated on Sep 30, 2023
Default Valuation
Create My Valuation Model
Other investors haven't shared any valuation models for Burning Rock Biotech Ltd.
Model Settings
Discount Rate
Forecast Period
5 Years
Terminal Growth
Discount Rate
Terminal Growth
Growth Period
5 Years
Copy as My Model

DCF Model
Base Case Scenario

Rotate your device to view
DCF Model

To view the process of deriving the DCF Value of one share from the estimated Present Value, see the DCF Value Calculation block.

DCF Value Calculation

Depending on which type of operating model is chosen (equity or whole firm valuation model), the resulting value is either the value of equity or the value of the entire firm. In the case of the latter, to move from the value of the firm to the value of equity, liabilities are subtracted and assets are added.

Capital Structure
From Present Value to DCF Value

Present Value -663.2m CNY
Equity Value -663.2m CNY
/ Shares Outstanding 103m
Value per Share -6.46 CNY
CNY / USD Exchange Rate 0.137
BNR DCF Value -0.88 USD
Overvalued by 100%

To view the process of calculating the Present Value of Burning Rock Biotech Ltd' future free cash flow, see the Present Value Calculation block.

Valuation Analysis

After the valuation process, in order to gain a deeper understanding of the relationship between risk and opportunity, it is useful to study the dynamic of company's valuation under various inputs to the DCF model in use.

DCF Financials
Financials used in DCF Calculation

684m 2.2B
Net Income
-347.4m 44.7m

Sensitivity Analysis
DCF Value Sensitivity Analysis

See Also

Other Stocks
What is the DCF value of one BNR stock?

Estimated DCF Value of one BNR stock is -0.88 USD. Compared to the current market price of 0.97 USD, the stock is Overvalued by 100%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Using the DCF Operating Model we project Burning Rock Biotech Ltd's future free cash flow and discount it at a selected discount rate to calculate its Present Value (-663.2m CNY).

2. DCF Value Calculation. We use the company's capital structure to calculate the total Equity Value based on the previously computed Present Value of the free cash flow. Dividing the Equity Value by the number of shares outstanding gives us the DCF Value of -0.88 USD per one BNR share.